Table 5.
Analysis of platelet aggregation rate induced by ADP.
Trials | MD (95% CI) | P value | |
---|---|---|---|
Chinese formula versus anti-platelet-aggregation drugs | |||
Tong xin luo capsule versus clopidogrel | 1 | 13.32 [7.68, 18.96] | <0.00001 |
Zhilong huoxue capsule versus aspirin | 1 | −5.50 [−10.49, −0.51] | 0.03 |
Di'ao xinxuekang capsule versus aspirin | 1 | −5.50 [−10.49, −0.51] | 0.03 |
| |||
Meta-analysis | 3 | 0.70 [−11.07, 12.48] | 0.91 |
| |||
Chinese formula plus anti-platelet-aggregation drugs versus anti-platelet-aggregation drugs | |||
Composite salvia dropping pill plus aspirin versus aspirin | 1 | −13.92 [−19.58, −8.26] | <0.00001 |
Huo xue capsule plus aspirin versus aspirin | 1 | −40.97 [−49.64, −32.30] | <0.00001 |
Tong xin luo capsule plus aspirin versus aspirin | 1 | −2.51 [−4.46, −0.56] | 0.01 |
Xinnao shutong capsule plus aspirin versus aspirin | 1 | −23.26 [−26.11, −20.41] | <0.00001 |
Xuefu zhuyu decoction plus aspirin versus aspirin | 1 | −16.82 [−22.12, −11.52] | <0.00001 |
Ginkgo biloba extract plus aspirin versus aspirin | 1 | −2.87 [−7.00, 1.26] | 0.17 |
| |||
Meta-analysis | 5 | −17.61 [−19.56, −15.65] | <0.00001 |